Loading…
Based on limited metadata from this May 2018 FDA Warning Letter, RemedyMart received enforcement action regarding an unspecified product category classified as "Other." Without access to the full letter text or subject line details, the specific nature of the violations cannot be determined from the available information. The issuing FDA office is also not documented in the metadata provided, limiting further assessment of the regulatory scope and product category involved.